Karen Lu

11PUBLICATIONS
152CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Feb 11, 2025
Use Patterns of Levonorgestrel-Releasing Intrauterine System among American Women.

Paul G Yeh, Allen Haas, Charlotte C Sun

|Jun 26, 2024
Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion.

Mikayla B Bowen, Brenda Melendez, Qian Zhang

|Apr 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers.

Ji Son, Yingao Zhang, Heather Lin

|Jan 09, 2024
Normal Risk Ovarian Screening Study: 21-Year Update.

Chae Young Han, Karen H Lu, Gwen Corrigan

|Nov 01, 2023
Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.

Erica M Bednar, J Alejandro Rauh-Hain, Jose J Garcia

Pageof 2